PP
Purple Biotech Ltd.
PPBT · NASDAQ
$1.84 +7.60% (+$0.13)
1M +18.71%
Market Cap $254.1K
P/E Ratio -
Div. Yield -
ROE 152.85%
Bulios Fair Price
$2.72
47.8% upside
Trenutna cena
$1.84
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica PPBT trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 0.02x
EV/EBITDA N/A
P/S N/A
Growth
0 /100
Declining Book val. growth 40.84%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 152.85%
ROA 173.94%
Asset turnover 0.00x
Debt
69 /100
Low Current ratio 3.70x
Int. coverage -3.82x
Debt/Equity 0.01x
Stability
19 /100
Unstable EPS volatility 14,444.23%
Profitable years 0
Beta -0.54x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PPBT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Gil Efron
Employees
10
Headquarters
Rehovot
Prihajajoči dogodki
13 NOV.
Earnings
Upcoming earnings report